Myeloid Neoplasm — Trials

Myeloid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,789 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 51–75 of 75 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01660906	Phase IV, Open-label, Multicenter Study of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients With Chronic, Low-grade Non-Hematologic Toxicity to Imatinib	completed	Phase 4	39	Bristol-Myers SquibbINDUSTRY	5	Nov 22, 2016	clinicaltrials
NCT01368523	Study of Oral AMN107 (Nilotinib) in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Previously Enrolled to CAMN107A2109 Trial	completed	Phase 4	19	Novartis PharmaceuticalsINDUSTRY